• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5-15 years in Australia.

作者信息

Wood Nicholas, Lopez Laura K, Glover Catherine, Leeb Alan, Cashman Patrick, Deng Lucy, Macartney Kristine

机构信息

National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia.

The University of Sydney Children's Hospital Westmead Clinical School, Westmead, New South Wales, Australia.

出版信息

Lancet Reg Health West Pac. 2023 Feb;31:100684. doi: 10.1016/j.lanwpc.2023.100684. Epub 2023 Jan 20.

DOI:10.1016/j.lanwpc.2023.100684
PMID:36694479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9854254/
Abstract
摘要

相似文献

1
Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5-15 years in Australia.澳大利亚5至15岁儿童接种新冠病毒mRNA疫苗的短期不良事件概况。
Lancet Reg Health West Pac. 2023 Feb;31:100684. doi: 10.1016/j.lanwpc.2023.100684. Epub 2023 Jan 20.
2
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.澳大利亚 COVID-19 疫苗的短期安全性：AusVaxSafety 主动监测，2021 年 2 月至 8 月。
Med J Aust. 2022 Aug 15;217(4):195-202. doi: 10.5694/mja2.51619. Epub 2022 Jul 4.
3
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
4
Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.青少年和年轻成年人风湿性疾病患者 COVID-19 疫苗相关不良事件的早期经验：一项单中心研究。
Int J Rheum Dis. 2022 Mar;25(3):353-363. doi: 10.1111/1756-185X.14279. Epub 2022 Jan 3.
5
COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.COVID-19 mRNA 疫苗在短期内通常是安全的：一项疫苗监测真实世界研究称。
Front Immunol. 2021 May 21;12:669010. doi: 10.3389/fimmu.2021.669010. eCollection 2021.
6
Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.日本对 BNT162b2 和 mRNA-1273 mRNA COVID-19 疫苗的不良反应。
J Infect Chemother. 2022 Apr;28(4):576-581. doi: 10.1016/j.jiac.2021.12.034. Epub 2022 Jan 11.
7
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.5岁及以上正在接受癌症和非恶性血液疾病治疗的儿童及青少年的新冠病毒疫苗接种：澳大利亚和新西兰儿童血液学/肿瘤学组共识声明
Med J Aust. 2022 Apr 4;216(6):312-319. doi: 10.5694/mja2.51444. Epub 2022 Mar 10.
8
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.与BNT162b2、Ad26.COV2.S和mRNA-1273新冠疫苗相关的严重不良反应：通过疫苗不良事件报告系统（VAERS）深入了解
Front Pharmacol. 2022 Nov 7;13:921760. doi: 10.3389/fphar.2022.921760. eCollection 2022.
9
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.mRNA COVID-19 疫苗接种后的心脏并发症：病例报告和病例系列的系统评价。
Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17.
10
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎疫苗在青少年、儿童和婴儿中的安全性、免疫原性和有效性：系统评价和荟萃分析。
Front Public Health. 2022 Apr 14;10:829176. doi: 10.3389/fpubh.2022.829176. eCollection 2022.

引用本文的文献

1
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.在智利一项针对3至17岁儿童人群的开放标签研究中，灭活SARS-CoV-2疫苗（科兴新冠疫苗）根据年龄组呈现出不同的安全性模式。
Vaccines (Basel). 2023 Sep 26;11(10):1526. doi: 10.3390/vaccines11101526.
2
Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic review and meta-analysis.COVID-19 疫苗在 5-11 岁儿童中的安全性和有效性：系统评价和荟萃分析。
Lancet Child Adolesc Health. 2023 Jun;7(6):379-391. doi: 10.1016/S2352-4642(23)00078-0. Epub 2023 Apr 18.

本文引用的文献

1
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.澳大利亚 COVID-19 疫苗的短期安全性：AusVaxSafety 主动监测，2021 年 2 月至 8 月。
Med J Aust. 2022 Aug 15;217(4):195-202. doi: 10.5694/mja2.51619. Epub 2022 Jul 4.
2
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years.美国 5 至 11 岁儿童接种 COVID-19 疫苗的安全性。
Pediatrics. 2022 Aug 1;150(2). doi: 10.1542/peds.2022-057313.
3
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.mRNA-1273 新冠病毒疫苗在 6 至 11 岁儿童中的评估。
N Engl J Med. 2022 May 26;386(21):2011-2023. doi: 10.1056/NEJMoa2203315. Epub 2022 May 11.
4
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.2021 年 11 月 3 日至 12 月 19 日，美国 5-11 岁儿童的 COVID-19 疫苗安全性。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1755-1760. doi: 10.15585/mmwr.mm705152a1.
5
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
6
COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.COVID-19 mRNA 疫苗在短期内通常是安全的：一项疫苗监测真实世界研究称。
Front Immunol. 2021 May 21;12:669010. doi: 10.3389/fimmu.2021.669010. eCollection 2021.
7
Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.2017 季节性流感疫苗安全性主动监测：澳大利亚 6 个月及以上人群的观察性队列研究。
BMJ Open. 2018 Oct 18;8(10):e023263. doi: 10.1136/bmjopen-2018-023263.